S&P Futures
3,936.25 +20.00 (+0.51%) Dow Futures
31,602.00 +115.00 (+0.37%) Nasdaq Futures
12,221.00 +80.50 (+0.66%) Russell 2000 Futures
1,770.80 +9.10 (+0.52%) Crude Oil
106.85 -0.77 (-0.72%) Gold
1,842.20 +11.90 (+0.65%)
DarioHealth Corp. (DRIO)
After hours:
Chart Events
Performance Outlook
| Previous Close | 5.21 |
| Open | 5.30 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 1000 |
| Day's Range | 5.08 - 5.33 |
| 52 Week Range | 4.11 - 23.36 |
| Volume | |
| Avg. Volume | 289,730 |
| Market Cap | 116.749M |
| Beta (5Y Monthly) | 1.35 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.47 |
| Earnings Date | Aug 15, 2022 - Aug 19, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 18.34 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for DRIO
Related Research
- DarioHealth Corp.Analyst Report: Johnson & JohnsonJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total revenue is generated in the United States.RatingFair ValueEconomic Moat3 days agoMorningstar
- PR Newswire
DarioHealth Announces New Contract with a National Employer
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced a new contract to deliver its digital behavioral health solution for a leading provider of integrated technology solutions for financial professionals. The new account is expected to launch in the third quarter of 2022.
- PR Newswire
Solera Health Adds DarioHealth to Its Cardiometabolic Network to Offer Hypertension Management Solutions
Solera Health, the premier platform for connecting people seamlessly and easily to proven, personalized health solutions, announces its partnership with DarioHealth, a leading digital therapeutics company revolutionizing how people with chronic conditions manage their health through a user-centric platform. Together, Solera and DarioHealth are offering a turnkey, world class solution for treating hypertension, requiring just one contract and one technical integration to make this compelling new
- PR Newswire
DarioHealth Secures $50 Million Dollar Non-Dilutive Credit Facility with OrbiMed
DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, announced today it closed a senior secured term loan facility of up to $50 million with OrbiMed, a leading investor in the healthcare industry, providing non-dilutive capital to fund the continued development of its platform and the acceleration of its adoption in the multi-billion dollar global chronic disease management market.
